|
End-of-day quote
Australian S.E.
|
||
| - | - |
|
| Manager | Title | Age | Since |
|---|---|---|---|
Andrew Nash
CEO | Chief Executive Officer | - | - |
Andrew Boyd
DFI | Director of Finance/CFO | - | 28/02/2011 |
| Corporate Officer/Principal | - | 28/02/2011 |
| Director | Title | Age | Since |
|---|---|---|---|
Andrew Nash
BRD | Director/Board Member | - | 28/02/2011 |
Brian McNamee
BRD | Director/Board Member | 70 | - |
Antoni M. Cipa
BRD | Director/Board Member | - | - |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -1.78% | -5.95% | +42.72% | -4.51% | 79.21B | |
| -1.42% | -4.24% | -18.81% | -37.78% | 58.22B | |
| +0.74% | -8.23% | +461.99% | +26.92% | 54.54B | |
| -2.00% | -3.66% | -10.49% | +27.83% | 48.89B | |
| +2.38% | -1.95% | -1.57% | +150.55% | 44.72B | |
| +2.23% | -4.04% | +51.06% | -16.82% | 31.83B | |
| -2.17% | -3.69% | +42.93% | +92.69% | 24.99B | |
| -0.85% | -8.64% | -3.66% | +144.26% | 20.95B | |
| 0.00% | -3.61% | +63.58% | +97.66% | 15.8B | |
| Average | -0.54% | -5.11% | +69.75% | +53.42% | 42.13B | |
| Weighted average by Cap. | -0.74% | -5.15% | +80.52% | +35.21% |
Employees
-
Sector
Pharmaceuticals
- Stock Market
- Stocks
- ZTL Stock
Select your edition
All financial news and data tailored to specific country editions
